Please login to the form below

ribociclib

This page shows the latest ribociclib news and features for those working in and with pharma, biotech and healthcare.

NICE gives Lilly’s Verzenios chance to compete with rivals

Novartis’ Kisqali (ribociclib) is far behind Pfizer’s drug (but expected to hit $1.6bn in 2022 according to EvaluatePharma), with Verzenios expected to give Kisquali competition for second place in ... Abemaciclib has been shown to be just as

Latest news

CHMP backs Sanofi’s all-oral sleeping sickness drug

Among these, Novartis’ CDK4/6 inhibitor Kisqali (ribociclib) was recommended for the treatment of women with hormone receptor-positive, HER2-negative locally advanced or metastatic breast cancer in combination with fulvestrant
Novartis claims a rare win at ESMO for PI3K inhibitor class

6 inhibitor, a newer drug group which includes Novartis’ own Kisqali (ribociclib), Pfizer’s Ibrance (palbociclib) and Eli Lilly’s Verzenio (abemaciclib).
Lilly gets EMA nod for Verzenio in breast cancer

46% to $3.1bn last year and is predicted to become a $6bn product at peak by EvaluatePharma - as well as Novartis’ second-to-market CDK4/6 inhibitor Kisqali (ribociclib).
Novartis considers filings for PI3K drug in breast cancer

own Kisqali (ribociclib) and Eli Lilly’s Verzenio (abemaciclib).
FDA backs earlier use of Lilly’s breast cancer drug Verzenio

year and is predicted to become a $6bn product at peak by EvaluatePharma - as well as Novartis’ second-to-market CDK4/6 inhibitor Kisqali (ribociclib)).

More from news
Approximately 4 fully matching, plus 25 partially matching documents found.

Latest appointments

Ipsen boosts specialty care and R&D leadership teams

East. Most recently, Semerjian served as senior vice president and global launch head of ribociclib.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Associate Director: £75, 000-90, 000

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

Account Director, Healthcare Marketing Agency: Salary TBC

Account Director: Competitive Salary Offered

Engagement Expert, Healthcare Brand Communications, London: Excellent package

Senior Account Manager, Rare Diseases – Medical Communications, ...: Excellent package

Senior Medical Writer: Salary TBC

Account Director – Healthcare Marketing – Berks: Salary TBC

Account Director – Health Policy – Global Agency: Salary TBC

Account Director, Medical Education: Salary TBC

Account Manager / Account Director: Competative

Global Business Development Director – Health Education: excellent commission

Client Services Director – Medical Education Agency – North West...: Salary TBC

Medical Writer: Salary TBC

Business Director: Competitive Salary Offered

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Account Manager / Senior Account Manager: 35, 000-40, 000

Senior Account Manager: Competitive Salary Offered

Editorial Assistant Medical Education Agency: £25, 000 - £26, 000

Senior Account Director development role to Business Director, H...: Excellent package

Home-based Senior Project Manager – Independent Med Ed: Salary TBC

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Clark Health Communications

Clark Health Communications (CHC) is an independent, award-winning health and medical communications agency. Our collaboration with experts and advocates enhances...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?: Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement: Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape: Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....